A VALIDATION, WITH NEW CLINICAL APPLICABILITY, OF A CLINICAL‐GENETIC RISK MODEL THAT PREDICTS THROMBOSIS WITH HIGH SENSITIVITY IN PATIENTS WITH LYMPHOMA | Publicación